faronoltinib   Click here for help

GtoPdb Ligand ID: 10549

Synonyms: compound 18e [PMID: 31670517]
PDB Ligand Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: Compound 18e is an optimised, orally bioavailable dual Janus kinase 2 (JAK2)/fms related tyrosine kinase 3 (FLT3) inhibitor [1]. It exhibits anti-tumour activity in vitro and in vivo. The chemical structure was matched to that for the INN faronoltinib, as disclosed in WHO INN Proposed List 135 (July 2026).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 2
Rotatable bonds 8
Topological polar surface area 82.34
Molecular weight 467.28
XLogP 3.48
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OCCN(C1CCN(CC1)c1ccc(cc1F)Nc1ncc(c(n1)c1cnn(c1)C(C)C)C)C
Isomeric SMILES OCCN(C1CCN(CC1)c1ccc(cc1F)Nc1ncc(c(n1)c1cnn(c1)C(C)C)C)C
InChI InChI=1S/C25H34FN7O/c1-17(2)33-16-19(15-28-33)24-18(3)14-27-25(30-24)29-20-5-6-23(22(26)13-20)32-9-7-21(8-10-32)31(4)11-12-34/h5-6,13-17,21,34H,7-12H2,1-4H3,(H,27,29,30)
InChI Key CVLXNRIQVFIVGY-UHFFFAOYSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Bioactivity Comments
Compound 18e has 37-fold and 56-fold selectivity for JAK2 over JAK1 and JAK3, respectively in biochemical assay. Selectivity for JAK2 is higher in cellular assays [1]. It inhibits proliferation of Ba/F3-JAK2V617F cells and JAK2V617F-overexpressing SET-2 cells with IC50s of 145 and 270 nM, respectively. It retains inhibitory activity for the FLT3D835Y mutation (IC50 4 nM). In vivo, compound 18e inhibits tumour growth in the MV4-11 and SET-2 xenograft tumour models.
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
Janus kinase 2 Hs Inhibitor Inhibition 9.1 pIC50 - 1
⤷ pIC50 9.1 (IC50 7x10-10 M) [1]
Janus kinase 1 Hs Inhibitor Inhibition 7.6 pIC50 - 1
⤷ pIC50 7.6 (IC50 2.6x10-8 M) [1]
Janus kinase 3 Hs Inhibitor Inhibition 7.4 pIC50 - 1
⤷ pIC50 7.4 (IC50 3.9x10-8 M) [1]
Selectivity at catalytic receptors
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
fms related receptor tyrosine kinase 3 Hs Inhibitor Inhibition 8.4 pIC50 - 1
⤷ pIC50 8.4 (IC50 4x10-9 M) [1]